
Reflecting on Rare Disease Day: Awareness is an Act of Love – Guest Article by Rareatives
As our commemoration of Rare Disease Day 2026, we are pleased to present a guest article by Jessica Lynn at

As our commemoration of Rare Disease Day 2026, we are pleased to present a guest article by Jessica Lynn at

By Léon Van Wouwe, Clinical Innovation Director, Volv Global Introduction Earlier cancer detection remains one of the most powerful opportunities

Finding the Patients We’re Missing Rare diseases often remain undiagnosed for years, leaving patients without timely treatment and care. Despite

Introduction Volv Global participation in Faces of Industrial Research 2026 reflects its commitment to connecting scientific innovation with real-world healthcare

In 2024, Sanofi – working in partnership with The BMJ – released the Rairity: Air Time For Rare Diseases podcast

By Léon Van Wouwe, Clinical Innovation Director, Volv Global Introduction: COPD as a “Syndrome,” Not Just One Disease Chronic

“The patient voice” is shorthand for patients’ and caregivers’ lived experience—captured in a way that can inform decisions. In other

Photos from Digital Lounge @Davos. Volv Global CEO and founder Christopher Rudolf has been

By Léon Van Wouwe, Clinical Innovation Director, Volv Global Introduction: A Silent Disease Becoming a Public Health Emergency Metabolic

By Léon Van Wouwe, Clinical Innovation Director, Volv Global Knowing When To Treat – AI for Transformation, Infection Risk, and

By Léon Van Wouwe, Clinical Innovation Director, Volv Global Early detection and personalised treatment in chronic lymphocytic leukaemia (CLL) remain

Artificial intelligence continues to redefine clinical development yet much of the conversation remains driven by hype rather than hard evidence.